Propanc Biopharma, Inc.: Form 10-Q for the period ended Nov 13, 2013
Filed with the SEC on Nov 14, 2013 and accepted by EDGAR at Nov 14, 2013, 15:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-11-13. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Shares outstanding | At period end2013-11-14 | 72,629,768 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001354488-13-006349. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.